Leaders in the fields of psychedelics and cannabis will join together for the GCI Virtual Summit.
The GCI Summit will feature a world-class lineup of thought leaders in psychedelics and cannabis from around the globe.
The event will offer a unique experience for participating leaders who can customise their programme across seven virtual topic areas from the comfort of their homes.
Topics include:
- Research and applied science
- Medicine, treatment and patients
- Psychedelics
- Regulations and international markets
- Consumer brands and retail
- Investment and finance
- Cultivation, operations and tech
Attendees will also have the opportunity to network at the event as the virtual platform makes it easy to find like-minded leaders and schedule video meetings. Users will be able to submit information about themselves and the networking platform’s Artificial Intelligence (AI) will automatically suggest the leaders best suited to connect with, based on mutual interests and experience.
Some of the speakers featuring at the event include:
- Dr Anne Katrin Schlag, head of research, Drug Science
- Ronan Levy, co-founder and executive chairman, Field Trip Health
- Bruce Linton, serial founder, psychedelics and cannabis
- Tim Schlidt, co-founder and partner, Palo Santo
- Sean McLintock, founding partner, Neo Kuma Ventures
- Dr Grace Blest-Hopley, research director, Heroic Hearts Project
- Many More
The GCI Summit also aims to make education accessible, and so is allocating a significant proportion of tickets to be available for free for cannabis and psychedelic industry leaders. In addition to leaders in cannabis and psychedelics – doctors, researchers, investors, policymakers, patients and retailers interested in learning more from the experts can also apply for free tickets.
To find out more or to apply for a ticket please visit www.gcivirtualsummit.com.
